Molecular mechanisms of mucormycosis-The bitter and the sweet
- PMID: 28771587
- PMCID: PMC5542377
- DOI: 10.1371/journal.ppat.1006408
Molecular mechanisms of mucormycosis-The bitter and the sweet
Conflict of interest statement
ASI is a founder of Vitalex Biosciences, a company that is aiming to develop rapid diagnostics and immunotherapy for mucormycosis.
Figures
References
-
- Ibrahim AS, Edwards JEJ, Filler SG. Zygomycosis In: Dismukes WE, Pappas PG, Sobel JD, editors. Clinical mycology. New York: Oxford University Press; 2003. p. 241–51.
-
- Eucker J, Sezer O, Graf B, Possinger K. Mucormycoses. Mycoses. 2001;44(7–8):253–60. Epub 2001/11/21. . - PubMed
-
- Tribble DR, Rodriguez CJ. Combat-Related Invasive Fungal Wound Infections. Curr Fungal Infect Rep. 2014;8(4):277–86. doi: 10.1007/s12281-014-0205-y ; PubMed Central PMCID: PMCPMC4267292. - DOI - PMC - PubMed
-
- Neblett Fanfair R, Benedict K, Bos J, Bennett SD, Lo YC, Adebanjo T, et al. Necrotizing cutaneous mucormycosis after a tornado in Joplin, Missouri, in 2011. N Engl J Med. 2012;367(23):2214–25. doi: 10.1056/NEJMoa1204781 . - DOI - PubMed
-
- Andresen D, Donaldson A, Choo L, Knox A, Klaassen M, Ursic C, et al. Multifocal cutaneous mucormycosis complicating polymicrobial wound infections in a tsunami survivor from Sri Lanka. Lancet. 2005;365(9462):876–8. Epub 2005/03/09. doi: 10.1016/S0140-6736(05)71046-1 . - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
